Cargando…
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
Sarcopenia, the loss of skeletal muscle mass and function with age, was first recognized as a disease in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) (M62.84) and has recently attracted attention as aged populations increase. However, the diagnostic...
Autores principales: | Kwak, Ju Yeon, Kwon, Ki-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Geriatrics Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370765/ https://www.ncbi.nlm.nih.gov/pubmed/32743297 http://dx.doi.org/10.4235/agmr.19.0028 |
Ejemplares similares
-
Current Status of Sarcopenia in Korea: A Focus on Korean Geripausal Women
por: Park, Hyoung Moo
Publicado: (2018) -
Sarcopenia targeting with autophagy mechanism by exercise
por: Park, Sung Sup, et al.
Publicado: (2019) -
Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review
por: Jang, Jung Yoon, et al.
Publicado: (2023) -
Molecular mechanisms and therapeutic interventions in sarcopenia
por: Park, Sung Sup, et al.
Publicado: (2017) -
Current Nutritional and Pharmacological Approaches for Attenuating Sarcopenia
por: Sakuma, Kunihiro, et al.
Publicado: (2023)